1. Adding clinical markers of more severe form of intermediate-high risk pulmonary embolism improves risk stratification and possibly identifies candidates for fibrinolytic therapy. (2nd May 2022) Authors: Radovanovic, N; Radosavljevic-Radovanovic, M; Prodanovic, M; Savic Spasic, L; Lojovic, N; Kecman, E; Djekic, A Journal: European heart journal Issue: Volume 11(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗